Retraction Note: Cancer Cell International (2021) 21:360
10.1186/s12935-021-02019-2.
The Editors-in-Chief have retracted this article. After publication, concerns were raised regarding high similarity between Fig. 8D sh2 image in this article and Fig. 7C MCF-7/Tax si-LINC00160 in [1]. Additionally, the western blot images in this article appear similar to those in a number of other articles on non-coding RNAs published within a similar time frame.
The authors have stated that the images in Fig. 8D were provided by a third party, and were unable to provide the original western blot scan files for validation.
The Editors-in-Chief therefore no longer have confidence in the presented data.
Luo Jiang has stated on behalf of both authors that they agree to this retraction.
Footnotes
The online version of the original article can be found at 10.1186/s12935-021-02019-2.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reference
- 1.Wu H, Gu J, Zhou D, Cheng W, Wang Y, Wang Q, Wang X. LINC00160 mediated paclitaxel-and doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ. J Cell Mol Med. 2020;24(15):8589–602. 10.1111/jcmm.15487. [DOI] [PMC free article] [PubMed] [Google Scholar]